11
Participants
Start Date
June 30, 2007
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
bevacizumab
Given IV
placebo
Given IV
magnetic resonance imaging
quality-of-life assessment
M D Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH